ngwaahịa
-
EZER flu&COVID-19 Antigen Combo Nnwale ngwa ngwa
-
KaiBiLi COVID-19 Antigen (Ọkachamara)
-
KaiBiLi COVID-19 Neutralization Ab+ Ngwa ngwa ule
-
KaiBiLi Viral Transport Ọkara
-
KaiBiLi H. pylori Antigen Rapid Test
-
KaiBiLi COVID-19 IgG/IgM
-
Nnwale ngwa ngwa KaiBiLi flu&Covid-19 Antigen Duo
-
EZER NAAT SARS-CoV-2 ngwa RT-PCR ozugbo
-
Nyocha KaiBiLi COVID-19 Antigen Saliva
-
KaiBiLi COVID-19 Antibody Neutralization
ngwa
gbasara Anyị
Banyere nkọwa ụlọ ọrụ
ihe anyi na eme
Hangzhou Genesis Biodetection na Biocontrol Co., Ltd. (GENESIS), Eguzobere na 2002, dị ka onye na-emepụta ngwaọrụ nyocha in-vitro, bụ ọkachamara na nyocha, mmepe na imepụta ngwa ngwa ule ngwa ngwa, na ngwa POCT na ngwa ndị dị mkpa. Ndị otu R&D nke GENESIS na-edu ndị ọkà mmụta sayensị na ndị ọkà mmụta sayensị China si United States na Japan laghachi azụ, nwere ezigbo ndabere na ahụmịhe n'ọtụtụ ọzụzụ gụnyere microbiology, immunology na bayoloji molecular.
ozi
Akụkọ
Hangzhou Genesis Biodetection na Biocontrol Co., Ltd. (GENESIS), Eguzobere na 2002, dị ka onye na-emepụta ngwaọrụ nyocha in-vitro, bụ ọkachamara na nyocha, mmepe na imepụta ngwa ngwa ule ngwa ngwa, na ngwa POCT na mkpa.
Ọrịa ọhụrụ zuru ụwa ọnụ ọzọ, nke Omicron BA.2 kpatara
Ọrịa ọhụrụ zuru ụwa ọnụ ọzọ, nke Omicron BA.2 kpatara mgbe ntiwapụ Omicron na-ebelata na Canada,…
ọzọ>>Nnwale mgbochi mmadụ nwere ike bụrụ ihe ọzọ ma ọ bụ mejuo ọgwụ mgbochi COVID?
Nnwale mgbochi mmadụ nwere ike bụrụ ihe ọzọ ma ọ bụ mejuo ọgwụ mgbochi COVID?Ihe na-esonụ a...
ọzọ>>